# P3 Health Partners Inc.: filings

PIII · Nasdaq · CIK 1832511 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/piii.md) · [Financials](/companies/piii/financials.md) · [Filings](/companies/piii/filings.md) · [Insiders](/companies/piii/insiders.md)

## Reports and events: 137 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 80, 8-K 80, 424B3 28, 3 25, 4/A 19, DEFA14A 19, 10-Q 17, CORRESP 11, UPLOAD 11, SC 13D/A 10, EFFECT 9, SC 13G/A 9, SC 13G 7, 10-K 6, DEF 14A 6, POS AM 6, NT 10-Q 5, S-8 5, SC 13D 5, NT 10-K 4, S-1/A 4, PRE 14A 3, S-1 3, S-3 3, SCHEDULE 13D/A 3, 3/A 2, PRER14A 2, 10-K/A 1, 10-Q/A 1, 25-NSE 1, 424B4 1, 425 1, 8-A12B 1, 8-K/A 1, AW 1, CERT 1, DEFM14A 1, DRS 1, POS EX 1, PREM14A 1, S-8 POS 1, SC TO-C 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-09-11 | 20:28 ET | [8-K](/filings/0001832511-26-000036.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 5.03 Amendment to articles or bylaws | 0001832511-26-000036 |
| 2026-08-12 | 20:30 ET | [SCHEDULE 13D/A](/filings/0001104659-26-094924.md) | Ownership report, active investor, amended | 0001104659-26-094924 |
| 2026-08-10 | 20:13 ET | [10-Q](/filings/0001832511-26-000034.md) | Quarterly report, period 2026-06-30 | 0001832511-26-000034 |
| 2026-08-10 | 20:03 ET | [8-K](/filings/0001832511-26-000032.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001832511-26-000032 |
| 2026-07-06 | 21:02 ET | [8-K](/filings/0001832511-26-000029.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001832511-26-000029 |
| 2026-06-10 | 21:54 ET | [8-K](/filings/0001832511-26-000027.md) | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001832511-26-000027 |
| 2026-05-26 | 20:06 ET | [8-K](/filings/0001832511-26-000026.md) | 3.01 Delisting notice; 9.01 Financial statements and exhibits | 0001832511-26-000026 |
| 2026-05-15 | 20:58 ET | [8-K](/filings/0001832511-26-000024.md) | 3.01 Delisting notice; 8.01 Other events; 9.01 Financial statements and exhibits | 0001832511-26-000024 |
| 2026-05-14 | 20:29 ET | [10-Q](/filings/0001832511-26-000022.md) | Quarterly report, period 2026-03-31 | 0001832511-26-000022 |
| 2026-05-14 | 20:10 ET | [8-K](/filings/0001832511-26-000021.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001832511-26-000021 |
| 2026-04-30 | 20:16 ET | [DEF 14A](/filings/0001140361-26-018240.md) | Proxy statement, period 2026-06-09 | 0001140361-26-018240 |
| 2026-04-28 | 21:29 ET | [8-K](/filings/0001832511-26-000018.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 5.03 Amendment to articles or bylaws | 0001832511-26-000018 |
| 2026-03-26 | 20:09 ET | [10-K](/filings/0001832511-26-000011.md) | Annual report, period 2025-12-31 | 0001832511-26-000011 |
| 2026-03-26 | 20:06 ET | [8-K](/filings/0001832511-26-000010.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001832511-26-000010 |
| 2026-03-25 | 21:21 ET | [8-K](/filings/0001832511-26-000006.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001832511-26-000006 |
| 2026-02-17 | 21:04 ET | [8-K](/filings/0001832511-26-000005.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001832511-26-000005 |
| 2025-11-28 | 18:29 ET | [8-K](/filings/0001832511-25-000028.md) | 3.01 Delisting notice; 9.01 Financial statements and exhibits | 0001832511-25-000028 |
| 2025-11-14 | 23:16 ET | [10-Q](/filings/0001832511-25-000025.md) | Quarterly report, period 2025-09-30 | 0001832511-25-000025 |
| 2025-11-14 | 23:14 ET | [8-K](/filings/0001832511-25-000024.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001832511-25-000024 |
| 2025-11-14 | 23:14 ET | [8-K](/filings/0001832511-25-000023.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001832511-25-000023 |
| 2025-08-29 | 20:17 ET | [8-K](/filings/0001832511-25-000015.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001832511-25-000015 |
| 2025-08-14 | 20:56 ET | [10-Q](/filings/0001832511-25-000013.md) | Quarterly report, period 2025-06-30 | 0001832511-25-000013 |
| 2025-08-14 | 20:07 ET | [8-K](/filings/0001832511-25-000010.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001832511-25-000010 |
| 2025-07-09 | 14:40 ET | [8-K](/filings/0001628280-25-034559.md) | 5.02 Departure or appointment of officers or directors | 0001628280-25-034559 |
| 2025-06-10 | 22:11 ET | [8-K](/filings/0001628280-25-030297.md) | 5.07 Shareholder vote results | 0001628280-25-030297 |
| 2025-06-06 | 20:06 ET | [SCHEDULE 13D/A](/filings/0001213900-25-052103.md) | Ownership report, active investor, amended | 0001213900-25-052103 |
| 2025-06-03 | 21:21 ET | [8-K](/filings/0001628280-25-029146.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001628280-25-029146 |
| 2025-05-15 | 20:57 ET | [10-Q](/filings/0001628280-25-026021.md) | Quarterly report, period 2025-03-31 | 0001628280-25-026021 |
| 2025-05-15 | 20:16 ET | [8-K](/filings/0001628280-25-025928.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-25-025928 |
| 2025-04-29 | 20:27 ET | [DEF 14A](/filings/0001140361-25-016302.md) | Proxy statement, period 2025-06-04 | 0001140361-25-016302 |
| 2025-04-17 | 00:09 ET | [8-K](/filings/0001628280-25-018083.md) | 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001628280-25-018083 |
| 2025-04-04 | 20:59 ET | [8-K](/filings/0001628280-25-016833.md) | 8.01 Other events | 0001628280-25-016833 |
| 2025-04-03 | 23:06 ET | [8-K](/filings/0001628280-25-016337.md) | 5.07 Shareholder vote results | 0001628280-25-016337 |
| 2025-03-28 | 01:02 ET | [10-K](/filings/0001628280-25-015305.md) | Annual report, period 2024-12-31 | 0001628280-25-015305 |
| 2025-03-27 | 20:29 ET | [8-K](/filings/0001628280-25-015165.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-25-015165 |
| 2025-03-03 | 22:04 ET | [DEF 14A](/filings/0001140361-25-006787.md) | Proxy statement, period 2025-03-31 | 0001140361-25-006787 |
| 2025-02-18 | 12:48 ET | [8-K](/filings/0001628280-25-005930.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001628280-25-005930 |
| 2025-02-13 | 13:00 ET | [8-K](/filings/0001628280-25-005308.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-25-005308 |
| 2025-01-31 | 00:08 ET | [SCHEDULE 13D/A](/filings/0001213900-25-009005.md) | Ownership report, active investor, amended | 0001213900-25-009005 |
| 2024-12-17 | 21:25 ET | [8-K](/filings/0001628280-24-051677.md) | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001628280-24-051677 |
| 2024-11-12 | 21:26 ET | [10-Q](/filings/0001628280-24-047186.md) | Quarterly report, period 2024-09-30 | 0001628280-24-047186 |
| 2024-11-12 | 21:07 ET | [8-K](/filings/0001628280-24-047123.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-24-047123 |
| 2024-11-08 | 22:15 ET | [SC 13D/A](/filings/0001213900-24-095994.md) | Ownership report, active investor, amended | 0001213900-24-095994 |
| 2024-08-29 | 20:05 ET | [8-K](/filings/0001628280-24-038802.md) | 5.02 Departure or appointment of officers or directors | 0001628280-24-038802 |
| 2024-08-07 | 20:22 ET | [10-Q](/filings/0001628280-24-035649.md) | Quarterly report, period 2024-06-30 | 0001628280-24-035649 |
| 2024-08-07 | 20:06 ET | [8-K](/filings/0001628280-24-035600.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-24-035600 |
| 2024-06-26 | 20:30 ET | [SC 13D/A](/filings/0001193125-24-169102.md) | Ownership report, active investor, amended | 0001193125-24-169102 |
| 2024-06-07 | 20:53 ET | [8-K](/filings/0001628280-24-027325.md) | 5.07 Shareholder vote results | 0001628280-24-027325 |
| 2024-05-24 | 20:21 ET | [8-K](/filings/0001104659-24-065141.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001104659-24-065141 |
| 2024-05-23 | 12:43 ET | [8-K](/filings/0001104659-24-064559.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity | 0001104659-24-064559 |

Page 1 of 3. [Older](/companies/piii/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:15 ET. No prices; not investment advice.